Skin care product evaluation in a group of critically ill, premature neonates: a descriptive study.
OBJECTIVE
Cleansing, moisturizing, and protecting neonatal skin is important, but literature evaluating specific product lines is limited. The purpose of this study was to measure the influence of a skin care product line on overall skin condition, perineal erythema, and pain when applied to neonates in a neonatal intensive care unit (NICU).


METHODS
This was an open label, descriptive study. Comparisons were made between measurements taken at the beginning of the study to those at the end, on the same subjects.


METHODS
The study was conducted in a 41-bed NICU at Driscoll Children's Hospital in Corpus Christi, Texas, that serves 31 counties in the region. This NICU treats children needing level 2 and 3 care, with a 1:1 or 2:1 nurse staffing ratio. This is not a birthing center; patients come from other community hospitals. Twenty-nine neonates participated in the study; their average body weight was 1.39 kg (3.06 lb) and their average gestation was 31.7 weeks.


METHODS
A skin care product line was introduced into a neonatal intensive care unit for 14 days. The products included 2 cleansers, 2 moisturizers, and a skin protectant with zinc oxide. Three outcome measures were tracked: Neonatal Skin Condition Score (NSCS), Skin Erythema Scale (SES), and pain. Nurses were also given a product evaluation survey. Descriptive statistics were used to report percentages and trends. Paired t tests were used to compare the mean NSCS, SES, and pain scores from the first 2 days a subject was in the study to the mean of the scores from the last 2 days they were in the study.


RESULTS
Subjects experienced approximately 1774 exposures to individual products during data collection. No differences were found in pain scores (P = .132), SES score (P = .059), or NSCS (P = .603) when mean values were compared at the beginning and end of the study. Analysis of the product evaluation survey for questions on cleaning, moisturizing, and reducing discomfort found that more than 90% of nurses ranked the new products as better than or equal to similar products used previously.


CONCLUSIONS
Use of a skin care product line was not associated with significant increases in overall neonatal skin condition measured with the NSCS, perineal erythema measured with the SES, or pain. The nurses caring for the subjects in this study prefer these products to others they have used in the past.
Daniel L. Young, PT, DPT, Associate Professor, Department of Physical Therapy, School of Allied Health Sciences, University of Nevada, Las Vegas. Debashish Chakravarthy, PhD, FAPWCA, Vice President, Clinical and Technical Strategy, Skin and Wound Care Division, Medline Industries, Inc, Mundelein, Illinois. Edward Drower, MS, Clinical Project Director, Research and Development, Medline Industries, Inc., Mundelein, Illinois. Roxana Reyna, BSN, RNC-NIC, WCC, Skin & Wound Prevention Specialist, Driscoll Children's Hospital, Corpus Christi, Texas.
Daniel L
DL
Young
Debashish
D
Chakravarthy
Edward
E
Drower
Roxana
R
Reyna
D016638:Critical Illness / Q000451:nursing* / Q000628:therapy; D004341:Drug Evaluation; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal; D010146:Pain / Q000188:drug therapy*; D017592:Skin Care / Q000295:instrumentation / Q000379:methods* / Q000451:nursing; D063465:Skin Cream / Q000627:therapeutic use*; D011795:Surveys and Questionnaires